BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 18026134)

  • 21. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
    Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conditional deletion of insulin-like growth factor-I receptor in prostate epithelium.
    Sutherland BW; Knoblaugh SE; Kaplan-Lefko PJ; Wang F; Holzenberger M; Greenberg NM
    Cancer Res; 2008 May; 68(9):3495-504. PubMed ID: 18451178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer.
    Adhami VM; Siddiqui IA; Ahmad N; Gupta S; Mukhtar H
    Cancer Res; 2004 Dec; 64(23):8715-22. PubMed ID: 15574782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interrelationships between dietary restriction, the IGF-I axis, and expression of vascular endothelial growth factor by prostate adenocarcinoma in rats.
    Powolny AA; Wang S; Carlton PS; Hoot DR; Clinton SK
    Mol Carcinog; 2008 Jun; 47(6):458-65. PubMed ID: 18058807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer.
    Ryan CJ; Haqq CM; Simko J; Nonaka DF; Chan JM; Weinberg V; Small EJ; Goldfine ID
    Urol Oncol; 2007; 25(2):134-40. PubMed ID: 17349528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implications of insulin-like growth factor-I for prostate cancer therapies.
    Kojima S; Inahara M; Suzuki H; Ichikawa T; Furuya Y
    Int J Urol; 2009 Feb; 16(2):161-7. PubMed ID: 19183230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel insights into the implication of the IGF-1 network in prostate cancer.
    Papatsoris AG; Karamouzis MV; Papavassiliou AG
    Trends Mol Med; 2005 Feb; 11(2):52-5. PubMed ID: 15694866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating IGF-1 and its role in cancer: lessons from the IGF-1 gene deletion (LID) mouse.
    Yakar S; Pennisi P; Zhao H; Zhang Y; LeRoith D
    Novartis Found Symp; 2004; 262():3-9; discussion 9-18, 265-8. PubMed ID: 15562820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide growth factors and prostate cancer: new models, new opportunities.
    Foster BA; Kaplan PJ; Greenberg NM
    Cancer Metastasis Rev; 1998-1999; 17(4):317-24. PubMed ID: 10453274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Histologic forms of benign prostatic hyperplasia: focus on fibroblastic factors].
    Cussenot O
    Ann Urol (Paris); 2006 Mar; 40 Spec No 1():4-6. PubMed ID: 16649582
    [No Abstract]   [Full Text] [Related]  

  • 31. A journey through your prostate.
    Kirby R
    Trans Med Soc Lond; 2002-2003; 119():53-75. PubMed ID: 17184032
    [No Abstract]   [Full Text] [Related]  

  • 32. Growth factors in the prostate.
    Matuo Y; Nishi N; Wada F
    Arch Androl; 1987; 19(3):193-210. PubMed ID: 2461175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obesity and prostate cancer.
    Freedland SJ; Aronson WJ
    Urology; 2005 Mar; 65(3):433-9. PubMed ID: 15780350
    [No Abstract]   [Full Text] [Related]  

  • 34. Insulin-like growth factor physiology and cancer risk.
    Pollak M
    Eur J Cancer; 2000 Jun; 36(10):1224-8. PubMed ID: 10882860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enforced epithelial expression of IGF-1 causes hyperplastic prostate growth while negative selection is requisite for spontaneous metastogenesis.
    Kaplan-Lefko PJ; Sutherland BW; Evangelou AI; Hadsell DL; Barrios RJ; Foster BA; Demayo F; Greenberg NM
    Oncogene; 2008 May; 27(20):2868-76. PubMed ID: 18026134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IGF-1 and prostate cancer.
    Roberts CT
    Novartis Found Symp; 2004; 262():193-9; discussion 199-204, 265-8. PubMed ID: 15562830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-like growth factors and their binding proteins in prostate cancer: cause or consequence?
    Meinbach DS; Lokeshwar BL
    Urol Oncol; 2006; 24(4):294-306. PubMed ID: 16818181
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.